Get the latest news and blog posts from APCI, including press releases and articles about advocacy actions, industry happenings, clinical pharmacy information, independent pharmacy operations, and much more.
TRICARE’s shrinking pharmacy network raises questions about patient choice, rural access, and whether current standards truly measure meaningful pharmacy access.
H.R. 6610 has cleared committee with overwhelming bipartisan support. Now independent pharmacy needs Congress to keep the Pharmacists Fight Back Act moving.
DSCSA Small Dispenser Exemption Extended Through Nov. 27, 2027
Smith Drug customers face a difficult transition. APCI can help pharmacy owners evaluate purchasing options, rebates, and next steps.
The Pharmacists Fight Back Act applies to one federal health program. If successful, it could become a model for broader pharmacy benefit manager reform efforts.
The House Oversight Committee advanced the Pharmacists Fight Back Act on a bipartisan 40–2 vote, moving H.R. 6610 one step closer to consideration by the full House.
APCI's Alabamians for Affordable Medications campaign has been recognized as a dual finalist in the international Content Marketing Awards after helping educate the public and support Alabama's landmark PBM reform legislation.
APCI’s Greg Reybold called for greater transparency and independent oversight of the TRICARE pharmacy program during a Senate hearing. Watch key exchanges on Express Scripts, community pharmacy access, mail-order costs, and the need for an independent audit.
In prepared remarks submitted before his Senate testimony, Reybold called for an independent audit of the TRICARE pharmacy program and reforms to protect beneficiary choice and community pharmacy access.
The co-op's vice president of healthcare policy will provide expert testimony on PBM practices during a July 15 Armed Services committee hearing examining the TRICARE Pharmacy Program.